Melanotan-2
MT-II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Synthetic analogue of α-MSH that stimulates melanogenesis for skin tanning and may increase sexual arousal.
Completed
PHASE2
NCT00000867
A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01920711
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
Novartis Pharmaceuticals
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT02201992
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
ECOG-ACRIN Cancer Research Group
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT03371719
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT01167712
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT00738881
Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT00993928
Home-Based Programs for Improving Sleep in Cancer Survivors
Alliance for Clinical Trials in Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02844816
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
NA
NCT06797050
A Story for Pepper & Nao
IRCCS Fondazione Stella Maris
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT02781610
Standardized Treatment of Pulmonary Exacerbations II
Chris Goss
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT00089323
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NSABP Foundation Inc
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00003127
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00770224
S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00217282
Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer
Mt. Sinai Medical Center, Miami
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00109837
S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01776424
Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease
Bayer
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT06389188
Effectiveness of Cervical Osteopathic Manipulation in Patients with Whiplash
Universidad Miguel Hernandez de Elche
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02273973
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
Genentech, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NCT05334069
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Alliance for Clinical Trials in Oncology
OBSERVATIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT00045617
S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025